Fulcrum Therapeutics (FULC) Other Accumulated Expenses: 2019-2025
Historic Other Accumulated Expenses for Fulcrum Therapeutics (FULC) over the last 7 years, with Sep 2025 value amounting to $236,000.
- Fulcrum Therapeutics' Other Accumulated Expenses fell 41.00% to $236,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $236,000, marking a year-over-year decrease of 41.00%. This contributed to the annual value of $463,000 for FY2024, which is 16.92% up from last year.
- According to the latest figures from Q3 2025, Fulcrum Therapeutics' Other Accumulated Expenses is $236,000, which was up 36.42% from $173,000 recorded in Q2 2025.
- In the past 5 years, Fulcrum Therapeutics' Other Accumulated Expenses registered a high of $463,000 during Q4 2024, and its lowest value of $9,000 during Q1 2023.
- For the 3-year period, Fulcrum Therapeutics' Other Accumulated Expenses averaged around $280,727, with its median value being $306,000 (2024).
- In the last 5 years, Fulcrum Therapeutics' Other Accumulated Expenses tumbled by 93.28% in 2023 and then soared by 4,177.78% in 2024.
- Fulcrum Therapeutics' Other Accumulated Expenses (Quarterly) stood at $74,000 in 2021, then skyrocketed by 41.89% to $105,000 in 2022, then soared by 277.14% to $396,000 in 2023, then climbed by 16.92% to $463,000 in 2024, then plummeted by 41.00% to $236,000 in 2025.
- Its Other Accumulated Expenses stands at $236,000 for Q3 2025, versus $173,000 for Q2 2025 and $441,000 for Q1 2025.